Induction of differentiation by 1α-hydroxyvitamin D5 in T47D human breast cancer cells and its interaction with vitamin D receptors

European Journal of Cancer

Volumn 36, Issue 6, 2000, Pages 780-786

  Lazzaro, G ^a   Agadir, A ^b   Qing, W ^a   Poria, M ^a   Mehta, R R ^a   Moriarty, R M ^a   Das Gupta, T K ^a   Zhang, X K ^b   Mehta, R G ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b BURNHAM INSTITUTE   (United States)

Author keywords

Breast cancer cells; Differentiation; MCF10; T47D; Vitamin D

Indexed keywords

1ALPHA HYDROXYVITAMIN D5; ACYLTRANSFERASE; COLECALCIFEROL; DIHYDROXYCOLECALCIFEROL; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR; 1 HYDROXYVITAMIN D5; 1-HYDROXYVITAMIN D5; CALCITRIOL; CALCITRIOL RECEPTOR; HYDROXYCOLECALCIFEROL; MESSENGER RNA;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BREAST TUMOR; CELL CULTURE; CELL DIVISION; DNA RESPONSIVE ELEMENT; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENETICS; METABOLISM; PATHOLOGY; TRANSACTIVATION;

BREAST NEOPLASMS; CALCITRIOL; CELL DIFFERENTIATION; CELL DIVISION; FEMALE; GENE EXPRESSION; HUMANS; HYDROXYCHOLECALCIFEROLS; RECEPTORS, CALCITRIOL; RESPONSE ELEMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED;

EID: 0033624987     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00016-2     Document Type: Article

References (28)

1. Colston K.W., Chander S.K., Mackay A.G., Coombes R.C. Effect of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro. Biochem. Pharmacol. 44:1992;693-702.
2. Danielpour D., Kadomatsu K., Anzano M.A., Smith J.M., Sporn M.B. Development and characterization of nontumorigenic and tumorigenic epithelial cell lines from rat dorsal lateral prostate. Cancer Res. 54:1994;3413-3421.
3. Colston K.W., Berger U., Coombes R.C. Possible role for vitamin D in controlling breast cancer cells proliferation. Lancet. 28:1989;188-191.
4. Bower M., Colston K.W., Stein R.C.et al. Topical calcipotriol treatment in advanced breast cancer. Lancet. 337:1991;701-702.
5. 3. Cancer Res. 47:1987;21-25.
6. 3 on metastasis of rat ascites hepatoma K-231. Br. J. Cancer. 50:1984;123-125.
7. 3 analogues. a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines Cancer Res. 55:1995;2822-2830.
8. 3. differential effects on leukemic cell growth, differentiation, and intestinal absorption Cancer Res. 50:1990;6857-6864.
9. 3 on the morphology of human breast cancer cell line BT 20. Differentiation. 40:1989;63-69.
10. Mathiasen I.S., Colston K.W., Binderup L. EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells. 1. J. Steroid. Biochem. Mol. Biol. 46:1993;365-371.
11. 3 and D Arch. Biochem. Biophys. 197:1979;119-125.
12. 5. J. Natl. Cancer Inst. 89:1997;212-218.
13. Mithasen I.S., Laderman U., Jattela M. Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by bcl-2 but does not involve capases or p53. Cancer Res. 59:1999;4848-4856.
14. Haussler M.R. Vitamin D receptors. nature and function Ann. Rev. Nutr. 6:1986;527-562.
15. Yu V.C., Delsert C., Andersen B.et al. RXRβ a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements Cell. 67:1991;1251-1266.
16. 3 signaling. Nature. 355:1992;446-449.
17. 3 receptor to its response elements. Proc. Natl. Acad. Sci. USA. 89:1992;256-260.
18. 3 receptors. Cell. 65:1991;1255-1266.
19. Ross T.K., Darwish H.M., Moss V.E., DeLuca H.F. Vitamin D-influenced gene expression via a ligand-independent, receptor-DNA complex intermediate. Proc. Natl. Acad. Sci. USA. 90:1993;9257-9260.
20. 3 receptor (VDR) homodimers into VDR-Retinoid X receptor heterodimers. Mol. Cell. Biol. 14:1994;3329-3338.
21. Agadir A., Lazzaro G., Zheng Y., Zhang X.-K., Mehta R.G. Resistance of HBL100 human breast epihthelial cells to vitamin D action. Carcinogensis. 20:1999;577-582.
22. Hecker KH, Roux KH. Touch Down RT-PCR for Better Resolution in BioTechniques 1996, 20, 478-485.
23. Wu Q., Li Y., Liu R., Agadir A., Lee -M., Liu Y., Zhang X-K. Modulation of retinoic acid sensitivity in lung cancer cells by a dynamic balance nur77 and COUP-TF orphan receptors and their heterodimerization. EMBO J. 16:1997;1656-1669.
24. Buras R.R., Schmaker L.M., Brenner R.V., Shabahang M., Nauta R.J., Evans S.R. Vitamin d receptors in breast cancer cells. Breast Cancer Res. Treat. 31:1994;191-202.
25. Darwish H., DeLuca H.F. Recent advances in the molecular biology of vitamin action. Prog. Nucl. Acid Res. Mol. Biol. 53:1996;321-344.
26. 3 regulation of c-myc protooncogene transcription. J. Biol. Chem. 264:1989;19710-19715.
27. 3 and antiestrogens in modulating apoptosis of breast cancer cells and tumors. Subcell. Biochem. 30:1998;245-270.
28. 3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells. Breast Cancer Res. Treat. 42:1997;31-41.